Drugs / Vi-DT
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03109600 | Apr → Sep 2017 | — | PT Bio Farma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vi-DT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03109600 ↗ |
| Modality | Vaccine | “Typhoid Conjugate Vaccine” NCT03109600 ↗ |